AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte Post author:Sam Post published:October 30, 2017 Post category:BioPharma Astra and Incyte are pushing forward on the development of immunotherapy combination treatments. Source: BioSpace You Might Also Like Amgen to Build New $300M Facility After Tax Changes February 1, 2018 Intralink Spine???s R??juve Treatment Nears Completion Of Safety Study And Begins Multi-Site Pivotal Study January 30, 2017 DBV Technologies Surges as Peanut Allergy Drug Passes Phase III Test November 19, 2017
Intralink Spine???s R??juve Treatment Nears Completion Of Safety Study And Begins Multi-Site Pivotal Study January 30, 2017